DELIX THERAPEUTICS Trademark

Trademark Overview

On Wednesday, May 12, 2021, a trademark application was filed for DELIX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DELIX THERAPEUTICS trademark a serial number of 90707362. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, August 6, 2024. This trademark is owned by Delix Therapeutics, Inc.. The DELIX THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the treatment of mental health conditions, namely, depression, anxiety, mood disorders, posttraumatic stress, cognitive, and neurodegenerative disorders; pharmaceutical products in the field of mental health diseases and disorders, namely, depression, anxiety, mood disorders, post-traumatic stress, cognitive, and neurodegenerative disorders

Pharmaceutical research and development in the field of mental health diseases and disorders; drug discovery services in the field of mental health diseases and disorders; laboratory research services relating to pharmaceuticals, namely, research in the field of mental health diseases and disorders
delix therapeutics

General Information

Serial Number90707362
Word MarkDELIX THERAPEUTICS
Filing DateWednesday, May 12, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2022

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of mental health conditions, namely, depression, anxiety, mood disorders, posttraumatic stress, cognitive, and neurodegenerative disorders; pharmaceutical products in the field of mental health diseases and disorders, namely, depression, anxiety, mood disorders, post-traumatic stress, cognitive, and neurodegenerative disorders
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development in the field of mental health diseases and disorders; drug discovery services in the field of mental health diseases and disorders; laboratory research services relating to pharmaceuticals, namely, research in the field of mental health diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDelix Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressConcord, MA 01742
Party NameDelix Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressConcord, MA 01742

Trademark Events

Event DateEvent Description
Friday, February 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 15, 2021NEW APPLICATION ENTERED
Thursday, August 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 19, 2022ASSIGNED TO EXAMINER
Wednesday, January 19, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 19, 2022NON-FINAL ACTION E-MAILED
Wednesday, January 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 29, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 25, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, April 27, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, May 16, 2022ASSIGNED TO PETITION STAFF
Friday, May 20, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Sunday, August 7, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, September 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 15, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, March 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 17, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 17, 2023SOU EXTENSION 1 FILED
Friday, March 17, 2023SOU EXTENSION 1 GRANTED
Tuesday, March 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 28, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 28, 2023SOU EXTENSION 2 FILED
Monday, August 28, 2023SOU EXTENSION 2 GRANTED
Tuesday, February 20, 2024SOU EXTENSION 3 GRANTED
Tuesday, August 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 6, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 6, 2024SOU EXTENSION 4 GRANTED
Tuesday, August 6, 2024SOU EXTENSION 4 FILED
Wednesday, February 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 20, 2024SOU EXTENSION 3 FILED
Tuesday, February 20, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

therapeutics delix disorders health mental field diseases pharmaceutical research namely services neurodegenerative